{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T10:24:51Z","timestamp":1758709491994},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2000,3,1]],"date-time":"2000-03-01T00:00:00Z","timestamp":951868800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Psychiatry Rep"],"published-print":{"date-parts":[[2000,3]]},"DOI":"10.1007\/s11920-000-0055-x","type":"journal-article","created":{"date-parts":[[2007,6,2]],"date-time":"2007-06-02T09:27:43Z","timestamp":1180776463000},"page":"117-123","source":"Crossref","is-referenced-by-count":17,"title":["Selective serotonin reuptake inhibitors for children and adolescents"],"prefix":"10.1007","volume":"2","author":[{"given":"Elizabeth A.","family":"Kastelic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.","family":"Labellarte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark A.","family":"Riddle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"55_CR1","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1001\/archpsyc.1997.01830230069010","volume":"54","author":"GJ Emslie","year":"1997","unstructured":"Emslie GJ, Rush AJ, Weinberg WA, et al.: A double blind randomized, placebo controlled trial of fluoxetine in children and adolescents with depression. Arch Gen Psychiatry 1997, 54:1031\u20131037.","journal-title":"Arch Gen Psychiatry"},{"key":"55_CR2","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1001\/archpsyc.1997.01830210119016","volume":"54","author":"B Vitiello","year":"1997","unstructured":"Vitiello, B and Jensen PS: Medication development and testing in children and adolescents: current problems, future directions. Arch Gen Psychiatry 1997, 54:871\u2013876.","journal-title":"Arch Gen Psychiatry"},{"key":"55_CR3","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1097\/00004583-199211000-00011","volume":"31","author":"MA Riddle","year":"1992","unstructured":"Riddle MA, Scahill L, King RA, et al.: Double-blind, crossover trial of fluoxetine and placebo in child and adolescent obsessive compulsive disorder. J Amer Acad Child Adolesc Psychiatry 1992, 31:1062\u20131069.","journal-title":"J Amer Acad Child Adolesc Psychiatry"},{"key":"55_CR4","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1001\/jama.280.20.1752","volume":"280","author":"JS March","year":"1998","unstructured":"March JS, Biederman J, Wolkrow R, et al.: Sertraline in children and adolescents with obsessive-compulsive disorder: a multicenter randomized controlled trial. JAMA 1998, 280:1752\u20131756.","journal-title":"JAMA"},{"key":"55_CR5","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/0278-5846(90)90050-Q","volume":"14","author":"JG Simeon","year":"1990","unstructured":"Simeon JG, Dinicola VF, Ferguson HB et al.: Adolescent depression: a placebo-controlled fluoxetine treatment study and follow-up. Prog Neuropsychopharm Biol Psychiatry 1990, 14:791\u2013795.","journal-title":"Prog Neuropsychopharm Biol Psychiatry"},{"key":"55_CR6","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/00002826-199304000-00009","volume":"16","author":"R Kurlan","year":"1993","unstructured":"Kurlan R, Como PG, Deeley C et al.: A pilot controlled study of fluoxetine for obsessive compulsive symptoms in children with Tourette\u2019s syndrome. Clin Neuropharmacol 1993, 16:167\u2013172.","journal-title":"Clin Neuropharmacol"},{"key":"55_CR7","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1089\/cap.1997.7.75","volume":"7","author":"L Scahill","year":"1997","unstructured":"Scahill L, Riddle MA, King RA, et al.: Fluoxetine has no marked effect on tic symptoms in patients with Tourette\u2019s syndrome: a double blind placebo controlled study. J Child Adolesc Psychopharmacol 1997, 7:75\u201385.","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"55_CR8","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1097\/00004583-199409000-00010","volume":"33","author":"B Black","year":"1994","unstructured":"Black B, Uhde TW: Treatment of elective mutism with fluoxetine: A double-blind, placebo-controlled study. J Am Acad Child Adolesc Psychiatry 1994, 33:1000\u20131006.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"55_CR9","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/S0002-7138(09)60602-6","volume":"25","author":"CJ Berg","year":"1986","unstructured":"Berg CJ, Rapoport JL, Flament M: The leyton obsessional inventory-child version. J Am Acad Child Psychiatry 1986, 25:84\u201391.","journal-title":"J Am Acad Child Psychiatry"},{"key":"55_CR10","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1097\/00004583-198907000-00015","volume":"28","author":"JF Leckman","year":"1989","unstructured":"Leckman JF, Riddle MA, Hardin MT, et al.: The yale global tic severity scale: initial testing of a clinician rated scale of tic severity. J Am Acad Child Adolesc Psychiatry 1989, 28:566\u2013573.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"55_CR11","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/00004583-199201000-00008","volume":"31","author":"J Veaugh-Geiss De","year":"1992","unstructured":"DeVeaugh-Geiss J, Moroz G, Biederman J, et al.: Clomipramine hydrochloride in childhood and adolescent obsessive-compulsive disorder: a multicenter trial. J Am Acad Child Adolesc Psychiatry 1992, 31:45\u201349.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"55_CR12","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1001\/archpsyc.1985.01790330057007","volume":"42","author":"MF Flament","year":"1985","unstructured":"Flament MF, Rapoport JL, Berg CJ, et al.: Clomipramine treatment of childhood obsessive-compulsive disorder. A doubleblind controlled study. Arch Gen Psychiatry 1985, 42:977\u2013983.","journal-title":"Arch Gen Psychiatry"},{"key":"55_CR13","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1001\/archpsyc.1989.01810120030006","volume":"46","author":"HL Leonard","year":"1989","unstructured":"Leonard HL, Swedo SE, Rapoport JL, et al.: Treatment of obsessive compulsive disorder with clomipramine and desipramine in children and adolescents. A double-blind cross over comparison. Arch Gen Psychiatry 1989, 46:1088\u20131092.","journal-title":"Arch Gen Psychiatry"},{"key":"55_CR14","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1097\/00004583-199706000-00023","volume":"36","author":"L Scahill","year":"1987","unstructured":"Scahill L, Riddle MA, McSwiggen-Hardin M, et al.: Children\u2019s yale brown obsessive compulsive scale: reliability and validity. J Am Acad Child Adoles Psychiatry 1987, 36:844\u2013852.","journal-title":"J Am Acad Child Adoles Psychiatry"},{"key":"55_CR15","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/S0193-953X(18)30214-4","volume":"15","author":"Wk Goodman","year":"1992","unstructured":"Goodman Wk, Price LH: Assessment of severity and change in obsessive compulsive disorder. Psychiatr Clin North Am 1992, 15:861\u2013869.","journal-title":"Psychiatr Clin North Am"},{"key":"55_CR16","unstructured":"Walkup JT, Reeve E, Yaryura-Tobias J, et al.: Fluvoxamine for childhood obsessive compulsive disorder: long-term treatment. Poster presented at the 38th annual New Clinical Drug Evaluation Unit meeting. Boca Raton, FL:June 10\u201330, 1998."},{"key":"55_CR17","doi-asserted-by":"crossref","unstructured":"Cook E, Wagner K, March J, et al.: Obsessive-compulsive disorder: long-term sertraline in children and adolescents. Poster presented at the 46th annual America Academy of Child and Adolescent Psychiatry and the 19th annual Academy of Child Psychiatry meeting. Chicago, IL: October 19\u201324, 1999.","DOI":"10.1097\/00004583-200110000-00011"},{"key":"55_CR18","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/j.2044-8260.1967.tb00530.x","volume":"6","author":"M Hamilton","year":"1967","unstructured":"Hamilton M: Development of a rating scale for primary depressive illness. Br J Soc Psychol 1967, 6:278\u2013296.","journal-title":"Br J Soc Psychol"},{"key":"55_CR19","first-page":"979","volume":"21","author":"EO Poznanski","year":"1985","unstructured":"Poznanski, EO, Freman LN, Mokros HB: Children\u2019s depression rating scale-revised. Psychopharmacol Bull 1985, 21:979\u2013989.","journal-title":"Psychopharmacol Bull"},{"key":"55_CR20","unstructured":"Wagner KD, Birmaher B, Carlson G, et al.: Multicenter trial of paroxetine and imipramine in the treatment of adolescent depression. Poster presented at the 45th annual America Academy of Child and Adolescent Psychiatry meeting. Anaheim, CA: October 27-November 1, 1998."},{"key":"55_CR21","unstructured":"Milin RP, Simeon J, Spenst W: Double-blind study of paroxetine in adolescents with unipolar major depression. Poster presented at the 46th annual America Academy of Child and Adolescent Psychiatry meeting. Chicago, IL: October 19\u201324, 1999."},{"key":"55_CR22","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1097\/00004583-199612000-00008","volume":"35","author":"B Birmaher","year":"1996","unstructured":"Birmaher B, Ryan N, Williamson, DE et al.: Childhood and adolescent depression: A review of the past 10 years. part II. J Am Acad Child Adolesc Psychiatry 1996, 35:1575\u20131583.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"55_CR23","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S1056-4993(18)30433-4","volume":"4","author":"C Kye","year":"1995","unstructured":"Kye C, Ryan N: Pharmacological treatment of child and adolescent depression. Child Adolesc Psychiatr Clin North Am 1995, 4:261\u2013281.","journal-title":"Child Adolesc Psychiatr Clin North Am"},{"key":"55_CR24","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/S0006-3223(99)00248-6","volume":"46","author":"MJ Labellarte","year":"1999","unstructured":"Labellarte MJ, Ginsburg GS, Walkup JT, Riddle MA: The treatment of anxiety disorders in children and adolescents. Biol Psychiatry 1999, 46:1567\u20131578.","journal-title":"Biol Psychiatry"},{"key":"55_CR25","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1097\/00004583-199804000-00016","volume":"37","author":"J Alderman","year":"1998","unstructured":"Alderman J, Wolkow R, Chung M, Johnston HF: Sertraline treatment of children and adolescents with obsessive-compulsive disorder or depression: pharmacokinetics, tolerability, and efficacy. J Am Acad Child Adolesc Psychiatry 1998, 37:386\u2013394.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"55_CR26","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1097\/00004583-199908000-00010","volume":"38","author":"RF Findling","year":"1999","unstructured":"Findling RF, Reed MD, Myers C, et al.: Paroxetine pharmacokinetics in depressed children and adolescents. J Am Acad Child Adolesc Psychiatry 1999, 38:952\u2013959.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"55_CR27","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/00004583-199804000-00024","volume":"37","author":"JR Oesterheld","year":"1998","unstructured":"Oesterheld JR, Shader RJ: Cytochromes: a primer for child and adolescent psychiatrists. J Am Acad Child Adolesc Psychiatry 1998, 37:447\u2013450.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"suppl 1","key":"55_CR28","doi-asserted-by":"crossref","first-page":"23S","DOI":"10.1097\/00004714-199910001-00003","volume":"19","author":"DJ Greenblatt","year":"1999","unstructured":"Greenblatt DJ, von Moltke LL, Harmatz JS, et al.: Human cytochromes and some newer antidepressants: kinetics, metabolism, and drug interactions. J Clin Psychopharm 1999 19(suppl 1):23S-35S.","journal-title":"J Clin Psychopharm"},{"key":"55_CR29","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1089\/cap.1990.1.193","volume":"1","author":"MA Riddle","year":"1991","unstructured":"Riddle MA, King RA, Hardin MT, et al.: Behavioral side effects of fluoxetine in children and adolescents. J Child Adolesc Psychopharmacol 1991, 1:193\u2013198.","journal-title":"J Child Adolesc Psychopharmacol"}],"container-title":["Current Psychiatry Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11920-000-0055-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11920-000-0055-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11920-000-0055-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T00:40:56Z","timestamp":1559436056000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11920-000-0055-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,3]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2000,3]]}},"alternative-id":["55"],"URL":"https:\/\/doi.org\/10.1007\/s11920-000-0055-x","relation":{},"ISSN":["1523-3812","1535-1645"],"issn-type":[{"value":"1523-3812","type":"print"},{"value":"1535-1645","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,3]]}}}